ALLOGENIC STEM CELL TRANSPLANTATION

Clinical trials for ALLOGENIC STEM CELL TRANSPLANTATION explained in plain language.

Never miss a new study

Get alerted when new ALLOGENIC STEM CELL TRANSPLANTATION trials appear

Sign up with your email to follow new studies for ALLOGENIC STEM CELL TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can donor immune cells tame stem cell transplant risks?

Disease control Not yet recruiting

This trial tests whether an experimental cell therapy called agenT-797 is safe for people receiving a stem cell transplant for blood cancers like leukemia or myelodysplastic syndrome. Participants get an infusion of agenT-797 about a week after their transplant. The main goal is …

Matched conditions: ALLOGENIC STEM CELL TRANSPLANTATION

Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: Disease control

Last updated Aug 13, 2026 00:00 UTC

ALLOGENIC STEM CELL TRANSPLANTATION

Get alerted when new ALLOGENIC STEM CELL TRANSPLANTATION trials appear

Can donor immune cells tame stem cell transplant risks?